4/11
07:06 am
avdl
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future [Yahoo! Finance]
4/9
08:09 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
4/2
03:50 am
avdl
Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution [Seeking Alpha]
Low
Report
Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution [Seeking Alpha]
4/1
08:19 am
avdl
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference [Yahoo! Finance]
4/1
08:00 am
avdl
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
Low
Report
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
3/5
02:15 pm
avdl
Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhang [Seeking Alpha]
Low
Report
Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhang [Seeking Alpha]
3/5
10:37 am
avdl
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/5
10:35 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Craig Hallum from $20.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Craig Hallum from $20.00 to $22.00. They now have a "buy" rating on the stock.
3/5
08:15 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Piper Sandler from $18.00 to $23.00. They now have an "overweight" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Piper Sandler from $18.00 to $23.00. They now have an "overweight" rating on the stock.
3/5
08:13 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Oppenheimer Holdings Inc. from $27.00 to $29.00. They now have an "outperform" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Oppenheimer Holdings Inc. from $27.00 to $29.00. They now have an "outperform" rating on the stock.
3/5
08:00 am
avdl
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Low
Report
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
3/5
07:43 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Needham & Company LLC from $20.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Needham & Company LLC from $20.00 to $22.00. They now have a "buy" rating on the stock.
3/5
07:43 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at HC Wainwright from $21.00 to $25.00. They now have a "buy" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at HC Wainwright from $21.00 to $25.00. They now have a "buy" rating on the stock.
3/4
03:37 pm
avdl
Avadel Pharmaceuticals Issues Statement On Patent Litigation
Low
Report
Avadel Pharmaceuticals Issues Statement On Patent Litigation
3/4
06:38 am
avdl
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/4
06:30 am
avdl
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
High
Report
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
3/1
09:18 am
avdl
With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing [Yahoo! Finance]
Medium
Report
With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing [Yahoo! Finance]
2/26
08:18 am
avdl
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4 [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4 [Yahoo! Finance]
2/26
08:00 am
avdl
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
Low
Report
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
2/7
08:00 am
avdl
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Medium
Report
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2/6
07:14 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $21.00 price target on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $21.00 price target on the stock.
1/30
05:50 am
avdl
Global Narcolepsy Drugs Market Forecast Reveals Surge to $6,138 Million by 2030 with Focus on Therapeutic Advancements [Yahoo! Finance]
Low
Report
Global Narcolepsy Drugs Market Forecast Reveals Surge to $6,138 Million by 2030 with Focus on Therapeutic Advancements [Yahoo! Finance]
1/30
05:45 am
avdl
Global Narcolepsy Drugs Market Forecast Reveals Surge to $6,138 Million by 2030 with Focus on Therapeutic Advancements
Low
Report
Global Narcolepsy Drugs Market Forecast Reveals Surge to $6,138 Million by 2030 with Focus on Therapeutic Advancements